ENPEP and breast cancer: Our data suggest that in some percentage of patients with breast cancer tumors, miR-125b downregulation consistently occurs; this involves a repression of the genes that code for ENPEP and CK2-α, and potentially MEGF9 and CCNJ (Figure 7E).